SecSonar.com

Artivion, Inc. (AORT)

Artivion, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Artivion, Inc. (AORT) is a Medical - Devices company based in US with a market capitalization of $1.1B. Revenue grew 13.6% year-over-year and free cash flow was negative at -$911K. This page tracks AORT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 1.6K employees · IPO Feb 12, 1993

Valuation

Valuation & price

$22.77 · as of May 17, 2026 · -52.2% vs 52w high

109.9

P/E ratio

Latest-FY diluted EPS

2.45

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$47.63$33.88$20.12Jul 25Dec 25Jul 26Jul 7, 25$30.29Jul 9, 25$32.15Jul 11, 25$31.46Jul 15, 25$31.19Jul 17, 25$30.85Jul 21, 25$30.64Jul 23, 25$31.24Jul 25, 25$31.40Jul 29, 25$31.50Jul 31, 25$30.91Aug 4, 25$32.06Aug 6, 25$32.27Aug 11, 25$42.96Aug 13, 25$43.73Aug 15, 25$42.81Aug 19, 25$42.02Aug 21, 25$43.14Aug 25, 25$43.57Aug 27, 25$43.74Aug 29, 25$43.93Sep 3, 25$43.32Sep 5, 25$43.49Sep 9, 25$42.45Sep 11, 25$42.31Sep 16, 25$39.56Sep 18, 25$41.36Sep 22, 25$41.10Sep 24, 25$40.91Sep 26, 25$41.06Sep 30, 25$42.34Oct 2, 25$40.59Oct 6, 25$40.75Oct 8, 25$40.99Oct 10, 25$40.20Oct 14, 25$41.02Oct 16, 25$41.54Oct 21, 25$42.30Oct 23, 25$43.40Oct 27, 25$44.74Oct 29, 25$44.99Oct 31, 25$45.37Nov 4, 25$45.76Nov 6, 25$47.50Nov 10, 25$44.98Nov 12, 25$47.63Nov 14, 25$45.70Nov 18, 25$44.83Nov 20, 25$44.08Nov 25, 25$46.83Nov 28, 25$46.66Dec 2, 25$45.37Dec 4, 25$45.41Dec 8, 25$44.07Dec 10, 25$44.21Dec 12, 25$45.12Dec 16, 25$45.91Dec 18, 25$47.15Dec 22, 25$46.87Dec 24, 25$46.89Dec 29, 25$46.33Jan 2, 26$44.46Jan 6, 26$45.36Jan 8, 26$44.85Jan 12, 26$42.89Jan 14, 26$42.50Jan 16, 26$43.39Jan 21, 26$44.31Jan 23, 26$43.02Jan 27, 26$41.48Jan 29, 26$40.42Feb 2, 26$41.23Feb 4, 26$40.07Feb 9, 26$39.61Feb 11, 26$40.10Feb 13, 26$36.60Feb 18, 26$37.52Feb 20, 26$38.33Feb 24, 26$35.35Feb 26, 26$38.08Mar 2, 26$38.55Mar 4, 26$38.50Mar 6, 26$37.04Mar 10, 26$35.96Mar 12, 26$36.17Mar 17, 26$37.48Mar 19, 26$36.53Mar 23, 26$35.72Mar 25, 26$36.12Mar 27, 26$35.29Mar 31, 26$36.62Apr 2, 26$34.17Apr 7, 26$35.22Apr 9, 26$36.51Apr 13, 26$38.57Apr 15, 26$37.47Apr 17, 26$37.72Apr 22, 26$37.03Apr 24, 26$37.76Apr 28, 26$36.33Apr 30, 26$35.83May 4, 26$35.53May 6, 26$34.73May 8, 26$25.41May 12, 26$23.10May 14, 26$22.93May 18, 26$23.76May 20, 26$22.67May 22, 26$22.46May 28, 26$22.57Jun 1, 26$21.05Jun 3, 26$20.58Jun 5, 26$20.12Jun 9, 26$20.88Jun 11, 26$20.60Jun 15, 26$21.07Jun 17, 26$21.20Jun 22, 26$20.13Jun 24, 26$22.03Jun 26, 26$23.61Jul 2, 26$23.97
$20.1052-week range$47.63
Loading valuation history…

Fundamentals

Key fundamentals

$1.1B

Market cap

13.6%

Revenue growth (YoY)

61.3%

Gross margin

-$911K

Free cash flow (USD)

$227.1M

Net debt

8.8%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$180.4MFY 2017$189.7MFY 2018$262.8MFY 2019$276.2MFY 2020$253.2MFY 2021$298.8MFY 2022$313.8MFY 2023$354.0MFY 2024$388.5MFY 2025$441.3M
$180.4M$441.3M

Free cash flow by year

2016 → 2025

FY 2016$12.3MFY 2017$3.8MFY 2018$4.1MFY 2019$7.8MFY 2020$5.0MFY 2021$-15.7MFY 2022$-15.9MFY 2023$11.4MFY 2024$11.0MFY 2025$-911.0K
$12.3M-$911K

Gross margin by year

2021 → 2025

FY 202166.1%FY 202264.5%FY 202364.7%FY 202464.0%FY 202561.3%
66.1%61.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $911K · 10b5-1 PlanGREEN ANDREW M · SVP, Regulatory and Quality · $910.7KJun 15, 2026Filing
  • 8-K eventSecurities Purchase AgreementMay 18, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 15, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventSecurities Purchase AgreementMay 7, 2026Filing

Questions

Frequently asked questions

What is Artivion, Inc.'s market cap?

Artivion, Inc. (AORT) has a market capitalization of $1.1B.

What is AORT's P/E ratio?

AORT trades at a price-to-earnings ratio of 109.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is AORT's price-to-book (P/B) ratio?

AORT trades at 2.45 times book value per share.

Are insiders buying AORT stock?

SEC Form 4 filings show no open-market insider buys at Artivion, Inc. in the last 90 days (1 sell).

Same arena

Related companies in Medical - Devices

CNMD

CONMED Corporation

$1.1B

BFLY

Butterfly Network, Inc.

$1.2B

AVNS

Avanos Medical, Inc.

$1.2B

TNDM

Tandem Diabetes Care, Inc.

$1.2B

IRMD

IRadimed Corporation

$1.2B

ATEC

Alphatec Holdings, Inc.

$1.2B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.